--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Libre von Abbott - DE" developer_entity: "Abbott Diabetes Care Inc." bundle_id: "com.abbott.adc.freestyle.libre.de" app_store_id: "6790581098" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-10-10" report_date: "2026-10-22" last_verified: "2026-10-22T00:00:00.000Z" report_version: "1.4.1" total_reviews: 0 sentiment: "Mixed" sentiment_score: 50 confidence: "medium" confidence_score: 0.45 top_complaint_theme: "Signal loss alarm fails to trigger despite users adjusting every available setting in the menu" review_sample_size: 2 total_review_count: 2 analyzed_review_count: 2 data_age_days: 5 momentum_velocity: "maintenance" intelligence_version: 2 tags: ["medical", "free", "mixed sentiment", "mobile app", "app review", "app analysis", "individuals", "diagnosed", "diabetes"] canonical_url: "https://marlvel.ai/apps/libre-von-abbott-de" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Libre von Abbott - DE Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free - **Signal**: Sentiment Mixed - **Recent focus**: Signal loss alarm fails to trigger despite users adjusting every available setting in the menu (top complaint) > **TL;DR:** Libre von Abbott - DE is a medical app by Abbott Diabetes Care Inc., with Mixed user sentiment (50/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Libre von Abbott - DE is a medical app by Abbott Diabetes Care Inc.. ## Quick Facts | Fact | Value | | :--- | :--- | | **User Mood** | Mixed | | **Category** | Medical | | **Developer** | Abbott Diabetes Care Inc. | | **Pricing** | Free | | **Platforms** | iOS & Android | | **Confidence** | Medium (0.45/1.0) | | **Data Age** | 5d | ## Metadata & Market Performance - **Publisher:** Abbott Diabetes Care Inc. - **Category:** Medical - **Target Audience:** Individuals diagnosed with diabetes requiring continuous glucose monitoring and their designated caregivers or healthcare providers. - **Platforms:** iOS & Android - **Version Reviewed:** 1.4.1 - **Report Date:** 2026-10-22 - **Signal Count:** 2 reviews analyzed - **Confidence:** Medium (0.45/1.0) - **App Store ID (iOS):** 6790581098 - **Bundle ID:** com.abbott.adc.freestyle.libre.de - **Google Play ID:** com.abbott.adc.freestyle.libre.de - **Data Window:** Analysis based on signals collected up to 2026-10-22 - **Short Description:** Abbott Diabetes Care ## Executive Snapshot **What it is:** Libre von Abbott is a continuous glucose monitoring companion app for Android and iOS that provides real-time sensor data and clinical sharing tools. **Why users hire it:** The app removes the friction of manual glucose logging by automating data capture and integrating it into the clinical management workflow of healthcare providers. ## App DNA (Features & Intent) - **[Standard] Continuous Glucose Monitoring:** Automatic glucose readings updated every minute on the smartphone display. * *User Intent:* Users expect intelligent, adaptive experiences that learn from their behavior. - **[Differentiator] Libre Assist:** Generative AI feature that predicts glucose impact based on user-provided meal photos. * *User Intent:* Users seek enhanced value through premium features. - **[Standard] Real-time Alerts:** Configurable glucose threshold notifications with adjustable volume and mute periods. * *User Intent:* Users want timely prompts to stay engaged without missing updates. - **[Differentiator] LibreView and LibreLinkUp Integration:** Cloud-based data sharing for glucose history with healthcare providers and caregivers. * *User Intent:* Users expect seamless access across multiple devices. ## Market Position {#market-position} Libre von Abbott holds the #6 position in the Medical category (DE), reflecting its role as a utility-focused companion for proprietary hardware. The lack of IAP monetization signals that its primary function is to secure the sensor-subscription funnel rather than generate direct app revenue. ## Monetization Strategy - **Model:** Free - **Tiers:** Free app with no IAP or subscription gates - **Analysis:** The app functions as a free companion tool for proprietary hardware sensors, with monetization tied to physical product sales. ## 🟡 User Sentiment (Medium Confidence: 2 of 2 reviews analyzed) {#user-sentiment} - **Overall Sentiment:** Mixed ### Top Complaints (Impact Areas) - **Signal loss alarm fails to trigger despite users adjusting every available setting in the menu** ## SWOT Analysis {#swot} **Core Strengths:** - Proprietary hardware integration creates high switching costs - Cloud-based provider connectivity embeds app into clinical workflows **Growth Levers:** - AI-driven meal insights could include automated carb-counting ## What's New - **Latest (v1.4.1, 1 weeks ago):** Deployed critical security patches. ## App Momentum (Maintenance) {#momentum} - Ships security updates at 9-week cadence. - No new features in recent releases. > **Cadence:** 2 total versions · 0 majors in last 6 months · 11 days since last update · 54 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} Libre von Abbott - DE is a medical app that is completely free. > **Bottom Line:** Libre von Abbott maintains its position through hardware lock-in, but the persistence of core utility failures (alarm and widget regressions) risks alienating the daily active user base. Addressing these stability issues is the necessary move to protect the sensor-subscription funnel. **Best for:** Individuals diagnosed with diabetes requiring continuous glucose monitoring and their designated caregivers or healthcare providers. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Rebuild alarm notification logic because signal loss alerts are failing → restore core safety utility ### Outlook: Mixed The market for CGM companion apps is shifting toward deeper clinical integration and AI-driven insights, areas where Libre von Abbott is well-positioned. However, the current failure to maintain basic utility features like alarms and widgets creates a vulnerability that could lead users to seek more reliable, albeit less integrated, alternatives. - 🔴 Persistent alarm failures and widget regressions in the latest release degrade core utility, which directly threatens long-term sensor subscription retention. - ⚪ The current maintenance-only release cadence suggests a focus on stability, yet the recent regressions indicate that current quality assurance processes are insufficient. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Sentiment | Mixed (50/100) | | Confidence | Medium | | Pricing Model | Free | | Platforms | iOS & Android | | Key Features | 4 analyzed | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Libre von Abbott - DE** (this app) | N/A/5 | Mixed | Abbott Diabetes Care Inc. | | [BabyMeasure: Growth Tracker](https://marlvel.ai/apps/babymeasure-growth-tracker) | N/A/5 | N/A | Emre HAMURCU | | [Lace Pro](https://marlvel.ai/apps/lace-pro) | 4.6/5 | Excited | Neurotone AI | | [Medical Abbreviations: Quick](https://marlvel.ai/apps/medical-abbreviations-quick) | 4.0/5 | Excited | VLR Software | | [Nursing Home Check](https://marlvel.ai/apps/nursing-home-check) | 3.7/5 | N/A | Alona Nesterenko | | [VetCore: Pet Health Records](https://marlvel.ai/apps/vetcore-pet-health-records) | N/A/5 | N/A | Dmitriy Motorin | ## Company Profile - **Developer:** Abbott Diabetes Care Inc. - **Website:** [https://www.FreeStyleLibre.com](https://www.FreeStyleLibre.com) - **Social:** [Instagram](https://www.instagram.com/freestylediabetes) · [Facebook](https://www.facebook.com/FreeStyleDiabetes) · [YouTube](https://www.youtube.com/freestyleus) ## Data Sources & Links - **App Store ID:** 6790581098 - **Google Play ID:** com.abbott.adc.freestyle.libre.de - **Dev Site:** [Official Website](https://www.FreeStyleLibre.com) - **Sources:** Developer website content, App store metadata, User reviews. ## Related Intel Reports - [*BabyMeasure: Growth Tracker*](https://marlvel.ai/apps/babymeasure-growth-tracker) (Emre HAMURCU) · N/A Rating - [*Lace Pro*](https://marlvel.ai/apps/lace-pro) (Neurotone AI) · 4.6/5 Rating | Positive Sentiment - [*Medical Abbreviations: Quick*](https://marlvel.ai/apps/medical-abbreviations-quick) (VLR Software) · 4.0/5 Rating | Positive Sentiment - [*Nursing Home Check*](https://marlvel.ai/apps/nursing-home-check) (Alona Nesterenko) · 3.7/5 Rating - [*VetCore: Pet Health Records*](https://marlvel.ai/apps/vetcore-pet-health-records) (Dmitriy Motorin) · N/A Rating - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.45/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 2 - **Data Sources:** user reviews, developer website, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 5 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/libre-von-abbott-de) Data licensed for AI Agent attribution under CC-BY-NC 4.0.